Marshall Wace’s Axsome Therapeutics AXSM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $5.92M | Sell |
56,716
-11,980
| -17% | -$1.25M | 0.01% | 975 |
|
|
2025
Q1 | $8.01M | Sell |
68,696
-58,401
| -46% | -$6.81M | 0.01% | 790 |
|
|
2024
Q4 | $10.8M | Buy |
+127,097
| New | +$10.8M | 0.01% | 708 |
|
|
2023
Q4 | – | Sell |
-59,248
| Closed | -$4.14M | – | 1843 |
|
|
2023
Q3 | $4.14M | Sell |
59,248
-132,263
| -69% | -$9.24M | 0.01% | 832 |
|
|
2023
Q2 | $13.8M | Buy |
191,511
+184,390
| +2,589% | +$13.3M | 0.03% | 536 |
|
|
2023
Q1 | $439K | Buy |
+7,121
| New | +$439K | ﹤0.01% | 1694 |
|
|
2022
Q3 | – | Sell |
-27,393
| Closed | -$1.05M | – | 2555 |
|
|
2022
Q2 | $1.05M | Buy |
+27,393
| New | +$1.05M | ﹤0.01% | 1853 |
|
|
2021
Q2 | – | Sell |
-23,374
| Closed | -$1.32M | – | 2103 |
|
|
2021
Q1 | $1.32M | Buy |
+23,374
| New | +$1.32M | 0.01% | 1287 |
|
|
2020
Q2 | – | Sell |
-79,454
| Closed | -$4.67M | – | 1514 |
|
|
2020
Q1 | $4.67M | Buy |
+79,454
| New | +$4.67M | 0.05% | 395 |
|